Halozyme Therapeutics, Inc

Senior Manager, Revenue & Gross-to-Net

Halozyme Therapeutics, Inc$150K — $175K *
Pharmaceuticals & Biotech
11 - 15 years of experience
Job Overview by Ladders

Qualifications

  • Bachelor's degree in Accounting, Finance, or related field (Master's preferred)
  • CPA or CMA required (active certification preferred)
  • Minimum 12 years of progressive finance and technical accounting experience, public accounting and/or public company experience
  • Minimum 5 years in pharmaceutical, biotech, life sciences, or healthcare gross-to-net accounting
  • Experience with ERP systems, particularly NetSuite
  • Experience working with third-party logistics and managed-care service providers

Responsibilities

  • Perform revenue and gross-to-net accounting close activities for partnered commercial products
  • Ensure accurate reporting of product revenue and gross-to-net reserves
  • Prepare and review journal entries, reconciliations, and reserve calculations
  • Manage partner pricing reconciliations, invoicing, and project accounting
  • Evaluate revenue contracts for compliance with ASC 606
  • Partner with cross-functional teams to support revenue analytics and budgeting
  • Drive process and system improvements for enhanced accuracy and efficiency

Benefits

  • Full and comprehensive benefit program including Employee Stock Purchase Program and 401(k) matching
  • Opportunities for growth in a culture prioritizing learning and development through in-house programs
  • Collaborative, innovative team environment that amplifies personal and professional impact
Full Job Description
Save time and apply through your LinkedIn account. Click the Apply with LinkedIn button and your LinkedIn profile will be imported into our site.

In order to move forward, you will need to create an account. Your password must be eight characters long, contain at least one special character, one capital letter and a number.

We look forward to discovering your talents.

How you will make an impact

The Senior Manager, Revenue & Gross-to-Net ("GTN") Accounting is a highly visible finance role responsible for complex revenue accounting, GTN analysis, project accounting, billing, accounts receivable, and revenue forecasting support for the Company's proprietary and partnered products. This role offers an experienced accounting professional the opportunity to apply technical expertise, commercial judgment, and cross-functional leadership to support accurate reporting, informed decision-making, and continuous improvement in a dynamic, innovation-focused environment.

This role can be based in either our San Diego, CA office or Ewing, NJ office

In this role, you'll have the opportunity to:
  • Perform revenue and gross-to-net accounting close activities for partnered commercial products and related revenue streams.
  • Ensure accurate reporting of product revenue, accounts receivable, distributor activity, and gross-to-net reserves.
  • Prepare and review journal entries, reconciliations, reserve calculations, and supporting analyses.
  • Manage partner pricing reconciliations, invoicing, project accounting, billing, and related accounts receivable activities.
  • Evaluate revenue contracts and commercial arrangements for compliance with ASC 606.
  • Partner cross-functionally to support revenue analytics, budgeting, forecasting, and business decisions.
  • Drive process, system, and control improvements to enhance accuracy, efficiency, and scalability.
  • Support audits and reviews with high-quality documentation and timely responses.
  • Maintain revenue accounting policies, procedures, and SOX controls.
  • Perform other duties as assigned.


To succeed in this role, you'll need:
  • Bachelor's degree in Accounting, Finance, or related field (Master's degree preferred).
  • CPA or CMA required (active certification preferred).
  • Minimum 12 years of progressive finance and technical accounting experience, including public accounting and/or public company experience.
  • Minimum 5 years of pharmaceutical, biotech, life sciences, or healthcare gross-to-net accounting experience.
  • Experience with ERP systems (NetSuite preferred).
  • Experience working with third-party logistics and managed-care service providers.


Preferred Qualifications:
  • Experience driving process improvement, automation, and scalable reporting solutions.
  • Strong knowledge of revenue recognition, gross-to-net accounting, internal controls, and SOX compliance.


Other Skills and Abilities:
  • Excellent communication, collaboration, and business partnership skills.
  • Strong analytical, technical accounting, and problem-solving capabilities.
  • High degree of accuracy, accountability, professional judgment, and attention to detail.
  • Ability to prioritize effectively and perform well in a fast-paced, complex environment.


In return, we offer you:
  • Full and comprehensive benefit program, including an Employee Stock Purchase Program and 401(k) matching.
  • Opportunities to grow in a culture that prioritizes learning, development and progression through in-house programs and tuition reimbursement.
  • A collaborative, innovative team that works as one to amplify your impact-on your career, the work you do and patients' lives.


The most likely base pay range for this position is $150K - $175K per year. Several factors, such as experience, tenure, skills, and particular business needs, will determine an individual's exact level of compensation. Base salary is only one element of employee compensation at Halozyme. Total compensation could include bonuses, sales incentives, and equity awards.

About Halozyme Therapeutics, Inc

Halozyme Therapeutics, Inc. is a biotechnology company focused on developing and commercializing novel oncology therapies that target the tumor microenvironment. The company's proprietary enzyme rHuPH20 is used to facilitate the delivery of injected drugs and fluids, potentially reducing the treatment burden of other drugs and improving patient convenience and compliance. Halozyme's lead investigational drug candidate, PEGPH20, is a PEGylated recombinant human hyaluronidase under clinical development for the treatment of pancreatic cancer and other solid tumors. The company was founded in 1998 and is headquartered in San Diego, California.
Learn more about Halozyme Therapeutics, Inc
Size
145 employees
Market Cap
$7.7 billion
Industry
Net Income
$129 million
Founded
1998
5 Year Trend
+24.8%
Revenue
$267.5 million
NASDAQ

Similar Jobs

More Jobs at Halozyme Therapeutics, Inc

More Pharmaceuticals & Biotech Jobs

Find similar Senior Manager, Revenue & Gross-to-Net jobs: